189 related articles for article (PubMed ID: 26956170)
1. Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases.
Yamada H; Yoneda M; Gosho M; Kato T; Zako M
BMC Ophthalmol; 2016 Mar; 16():26. PubMed ID: 26956170
[TBL] [Abstract][Full Text] [Related]
2. Effect of bimatoprost, latanoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human ciliary body smooth muscle cells.
Ooi YH; Oh DJ; Rhee DJ
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5259-65. PubMed ID: 19443729
[TBL] [Abstract][Full Text] [Related]
3. Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost.
Oh DJ; Martin JL; Williams AJ; Peck RE; Pokorny C; Russell P; Birk DE; Rhee DJ
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):953-63. PubMed ID: 16505029
[TBL] [Abstract][Full Text] [Related]
4. Effect of latanoprost on the expression of matrix metalloproteinases and their tissue inhibitors in human trabecular meshwork cells.
Oh DJ; Martin JL; Williams AJ; Russell P; Birk DE; Rhee DJ
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3887-95. PubMed ID: 16936101
[TBL] [Abstract][Full Text] [Related]
5. Effect of prostaglandin analogs: Latanoprost, bimatoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human trabecular meshwork endothelial cells.
Heo JY; Ooi YH; Rhee DJ
Exp Eye Res; 2020 May; 194():108019. PubMed ID: 32222455
[TBL] [Abstract][Full Text] [Related]
6. Latanoprost induces matrix metalloproteinase-1 expression in human nonpigmented ciliary epithelial cells through a cyclooxygenase-2-dependent mechanism.
Hinz B; Rösch S; Ramer R; Tamm ER; Brune K
FASEB J; 2005 Nov; 19(13):1929-31. PubMed ID: 16076963
[TBL] [Abstract][Full Text] [Related]
7. Latanoprost stimulates secretion of matrix metalloproteinases in tenon fibroblasts both in vitro and in vivo.
Mietz H; Esser JM; Welsandt G; Kociok N; Hueber A; Joussen A; Esser P; Krieglstein GK
Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5182-8. PubMed ID: 14638715
[TBL] [Abstract][Full Text] [Related]
8. Matrix Metalloproteinases and Glaucoma Treatment.
Weinreb RN; Robinson MR; Dibas M; Stamer WD
J Ocul Pharmacol Ther; 2020 May; 36(4):208-228. PubMed ID: 32233938
[TBL] [Abstract][Full Text] [Related]
9. Effects of Latanoprost and Bimatoprost on the Expression of Molecules Relevant to Ocular Inflow and Outflow Pathways.
Li X; He F; Gabelt BT; Wang Y; Cai S; Cao J; Fan N; Kaufman PL; Liu X
PLoS One; 2016; 11(3):e0151644. PubMed ID: 27011234
[TBL] [Abstract][Full Text] [Related]
10. Latanoprost's effects on TIMP-1 and TIMP-2 expression in human ciliary muscle cells.
Anthony TL; Lindsey JD; Weinreb RN
Invest Ophthalmol Vis Sci; 2002 Dec; 43(12):3705-11. PubMed ID: 12454040
[TBL] [Abstract][Full Text] [Related]
11. Effect of latanoprost acid and pilocarpine on cultured rabbit ciliary muscle cells.
Zhong Y; Gao J; Ye W; Huang P; Cheng Y; Jiao Q
Ophthalmic Res; 2007; 39(4):232-40. PubMed ID: 17622744
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin FP agonists alter metalloproteinase gene expression in sclera.
Weinreb RN; Lindsey JD; Marchenko G; Marchenko N; Angert M; Strongin A
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4368-77. PubMed ID: 15557445
[TBL] [Abstract][Full Text] [Related]
13. Synthesis pattern of matrix metalloproteinases (MMPs) and inhibitors (TIMPs) in human explant organ cultures after treatment with latanoprost and dexamethasone.
el-Shabrawi Y; Eckhardt M; Berghold A; Faulborn J; Auboeck L; Mangge H; Ardjomand N
Eye (Lond); 2000 Jun; 14 ( Pt 3A)():375-83. PubMed ID: 11027004
[TBL] [Abstract][Full Text] [Related]
14. Effect of latanoprost on the expression of matrix metalloproteinases and tissue inhibitor of metalloproteinase 1 on the ocular surface.
Honda N; Miyai T; Nejima R; Miyata K; Mimura T; Usui T; Aihara M; Araie M; Amano S
Arch Ophthalmol; 2010 Apr; 128(4):466-71. PubMed ID: 20385943
[TBL] [Abstract][Full Text] [Related]
15. Metalloproteinase gene transcription in human ciliary muscle cells with latanoprost.
Weinreb RN; Lindsey JD
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):716-22. PubMed ID: 11867589
[TBL] [Abstract][Full Text] [Related]
16. Infliximab counteracts tumor necrosis factor-α-enhanced induction of matrix metalloproteinases that degrade claudin and occludin in non-pigmented ciliary epithelium.
Yamada H; Yoneda M; Inaguma S; Watanabe D; Banno S; Yoshikawa K; Mizutani K; Iwaki M; Zako M
Biochem Pharmacol; 2013 Jun; 85(12):1770-82. PubMed ID: 23603294
[TBL] [Abstract][Full Text] [Related]
17. Eyelash growth induced by topical prostaglandin analogues, bimatoprost, tafluprost, travoprost, and latanoprost in rabbits.
Giannico AT; Lima L; Russ HH; Montiani-Ferreira F
J Ocul Pharmacol Ther; 2013 Nov; 29(9):817-20. PubMed ID: 23981234
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Prostaglandin Analogues on the Ciliary Zonular Fibers of the Rabbit Crystalline Lens.
Hwang HB; Kim SY
Curr Eye Res; 2018 Nov; 43(11):1357-1361. PubMed ID: 30015523
[TBL] [Abstract][Full Text] [Related]
19. Impact of prostaglandin glaucoma drops on platelet-activating factor action: an in vitro study.
Moschos MM; Nitoda E; Chatziralli IP; Panos GD; Demopoulos CA
Drug Des Devel Ther; 2016; 10():3977-3981. PubMed ID: 27994439
[TBL] [Abstract][Full Text] [Related]
20. Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor.
Sharif NA; Kelly CR; Crider JY
J Ocul Pharmacol Ther; 2002 Aug; 18(4):313-24. PubMed ID: 12222762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
